SSHA

Society of Sexual Health Advisers

Unite the union
  • About us
    • JOIN SSHA
    • Code of Professional Conduct
    • National Organising Professional Committee
    • National Organising Professional Committee Structure
    • Constitution and Rules
    • Council Reports
    • NPC ACCESS ONLY
  • News
  • Regions
    • London
    • North East, Yorkshire & Humberside – VACANT
    • Ireland
    • Scotland
    • South West – VACANT
    • East Midlands – VACANT
    • North West – VACANT
    • South East
    • Wales
    • West Midlands – VACANT
  • Resources
    • I Want To Be A Health Adviser
    • SSHA Manual
    • Conference Presentations
    • Competency Framework for Sexual Health Advisers
    • WeSSI: West Sussex Sexual Health Structured Interview
    • Research
    • Unite – Union
    • Publications
  • Jobs
    • Current Jobs
    • Sample Job Descriptions
  • Links
  • Sign up for the SSHA Newsletter
You are here: Home / Media Watch / Scottish campaigners call for ‘immediate’ access to HIV prevention drug

Scottish campaigners call for ‘immediate’ access to HIV prevention drug

August 7, 2016 By SSHA Leave a Comment

George_Valiotis_SSHA

7th August 2016
by Judith Duffy [Herald Scotland]
Article Link

Campaigners have called on the Scottish Government to follow the example of France and introduce a drug that can prevent HIV without waiting for it to be licensed.

The drug, called Truvada, triggered headlines last week after the High Court told the NHS in England it should fund the treatment, despite health bosses arguing it was the responsibility of councils.

Critics argued the drug could lead to irresponsible sexual behaviour – with some describing it as a “lifestyle drug” – and would strain scarce NHS resources. The drug, which studies have found could reduce the risk of infection by nearly 90 per cent, is expected to be of most benefit for gay men who are at higher risk of contracting HIV.

Charity HIV Scotland said ministers north of the border should follow the example of France, which last year said it would make the drug available for free before it was fully licensed for prevention, as a pre-exposure prophylaxis medication (PrEP). Truvada was originally developed for the treatment of HIV.

George Valiotis, chief executive of HIV Scotland, said: “In France, the health minister said last year we are not going to wait for licensing, we are going to do this now as it can make a real difference to transmission rates.

“We would hope the Scottish Government would take the same approach and say we will act now.

“For the last 10 years, there have been between 350 and 370 new cases of HIV a year in Scotland – that is in spite of rigorous, well-organised behaviour change programmes for the last 30 years. In Scotland nearly one in four people who have HIV don’t know they have it.

“We need something else and the evidence for PrEP shows it works in particular cases.”

In a statement issued following the ruling, NHS England said it would appeal against the High Court ruling and warned that funding PrEP, which could cost £10-£20 million a year, would hit the money available for treatments for diseases.

Christian organisation CARE for Scotland, said it was “a lifestyle drug” that could increase the risk of sexually transmitted diseases.

But Valiotis said: “We have had a lot of people telling us they feel stigmatised about how this is being discussed,

“We were really shocked to see NHS England comparing it to other diseases – you don’t see that being done for other treatments.”

Some Scots are already using the drug. Gordon, who did not want his full name to be used, has been taking it on a daily basis since January. He obtains a generic form of PrEP online, which costs around £45 a month, but emphasises he still also has regular check-ups and monitoring at a sexual health clinic.

He said: “The difference it has made is it is a reassurance – I used to worry all the time. People can have the virus without knowing, so they may be unknowingly transmitting HIV and people are unknowingly being infected as they don’t know the status of their partners. I don’t feel so nervous now.

“I don’t use it on its own, I still use condoms, but it has given me reassurance so I don’t need to worry about it.

“I have always been cautious, but some of my friends have been cautious and ended up getting up HIV. This drug, if it is taken properly on a daily basis, can make a huge difference to people.”

He added: “I remember when the Aids epidemic was at its height and people were dying and it took a long time for drugs to be made available that were effective to treat HIV. Now they have something they can stop transmission – so why is there all this negativity about it?

“I am being responsible to myself, but I am also being responsible to my sexual partners.”

Dr Jamie Franks, a senior lecturer in the school of health and life sciences at Glasgow Caledonian University, who has carried out studies into PrEP, said research had estimated that treating HIV over a lifetime adds up to around £400,000 per person for the cost of the drugs alone. The cost of Truvada at the moment is around £400 a month.

He said: “PrEP is very cost-effective as long as we give it to the people who are most likely to become infected with HIV.”

On the issue of it being a “lifestyle” drug, Franks added: “If only we all heeded what all of the health psychologists tell us to do all of the time, we would all be a lot healthier.

“When it comes to HIV and sex, it is the same as alcohol and smoking, getting a suntan and eating too much.”

Ingrid Young, research fellow at the MRC/CSO Social and Public Health Sciences Unit at Glasgow University, said the drug had to be viewed as part of a comprehensive sexual health package.

“It is one of many options and will depend on the person and their circumstances and what suits them best,” she said.

“We offer a range of contraceptive options to women – and it is fantastic to finally be able to have a range of things to offer to people who may be at risk of HIV.”

The Scottish Medicines Consortium, which assesses if drugs should be made available on the NHS, said an application for Truvada as PrEP had yet to be submitted, but it would be assessed on the usual criteria, including cost-effectiveness.

Health Secretary Shona Robison said the European Medicines Agency recommended granting a marketing authorisation for Truvada’s use as PrEP on July 22, which has been sent to the European Commission for adoption.

She added: “We would urge the European Commission to do this quickly.

“As soon as Truvada is licenced for PrEP we will call on its manufacturer to submit an application to the Scottish Medicines Consortium, at a fair price, so its routine use in Scotland can be considered as quickly as possible.”

Related Articles

  • NHS Scotland to fund 'game-changer' Prep HIV drug
  • The UK’s largest sexual health clinic saw a 40 percent drop in new HIV infections…
  • Every missed HIV diagnosis is a failure of care

Filed Under: Media Watch Tagged With: CARE for Scotland, European Medicines Agency, France, gay men, George Valiotis, Glasgow Caledonian University, Glasgow University, High Court, hiv, HIV Scotland, Ingrid Young, Jamie Franks, MRC/CSO Social and Public Health Sciences Unit, msm, NHS, nhs england, prep, scottish government, Scottish Medicines Consortium, Shona Robinson, truvada

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Search

Connect with SSHA

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

SSHA Newsletter

Learn about upcoming SSHA conferences and study days. Give SSHA policy/guideline feedback. Stay updated on BASHH, THT and Unite the Union issues. Sign up now!

Media Watch

10,000 people will be given the “Prep” drug in a three-year-long clinical trial.

NHS England has power to fund Prep HIV drug, court decides

NHS staff lay bare a bullying culture

Useful Links

  • BASHH
  • HPV Action
  • NAM
  • Public Health England
  • Terence Higgins Trust
  • UNITE the Union

Latest Tweets

Twitter
Tom McAlear
Tom McAlear
@tommcalear_GCU

pic.twitter.com/lon6…

reply retweet favourite
09:39 · November 12, 2019 ·
Retweeted by SSHA
Twitter
SSHA
SSHA
@ssha_info

WANTED. Sexual Health Adviser representative for BASHH Board. A key role within BASHH If interested please email Dr Alan Tang Secretary@bashh.net with a short CV explaining what you can bring to the role and how you will represent sexual health advisers in BASHH. @UniteinHealth

reply retweet favourite
12:36 · October 31, 2019
Twitter
SSHA
SSHA
@ssha_info

SSHA Conference 2019. - Liverpool. Congratulations Ceri Evans as the new President of SSHA. And a Thank you Martin Murchie as exiting President for 9 years. @UniteinHealth

reply retweet favourite
15:46 · September 21, 2019
Twitter
SSHA
SSHA
@ssha_info

SSHA Conference 2019. Informative afternoon speakers on SSHA AGM, SHA complex coding, First year of PrEP in Scotland, HIV and disclosure, Vicarious Trauma, Abstract writing, and Resilience. @UniteinHealth

reply retweet favourite
15:44 · September 21, 2019
Twitter
SSHA
SSHA
@ssha_info

Some places still available for The Society of Sexual Health Advisers Conference in Liverpool ssha.info twitter.com/ssha_inf…

reply retweet favourite
16:00 · September 9, 2019
Twitter
BHIVA
BHIVA
@BritishHIVAssoc

The recent outbreak of #HIV in Glasgow, is discussed here @BBCNews and how the team @WaverleyCare are tackling it bbc.co.uk/news/uk-sc…

reply retweet favourite
21:10 · August 19, 2019 ·
Retweeted by SSHA
Twitter
SSHA
SSHA
@ssha_info

bbc.com/news/uk-scot…

reply retweet favourite
21:07 · August 19, 2019
Twitter
SandyfordNHSggc
SandyfordNHSggc
@SandyfordNHSGGC

We've developed proposals to enable us to deliver better services. We’re keen to hear the views of the people who use our services, the public, partners, and organisations we work with and all interested stakeholders. See our public engagement page glasgowcity.hscp.sco…

reply retweet favourite
09:51 · August 8, 2019 ·
Retweeted by SSHA
Follow @ssha_info

Warning: Invalid argument supplied for foreach() in /home/ssha432/public_html/wp-content/plugins/custom-facebook-feed/custom-facebook-feed.php on line 1107

SSHA on Facebook

This message is only visible to admins.

Problem displaying Facebook posts.
Click to show error

Error: (#10) To use "Page Public Content Access", your use of this endpoint must be reviewed and approved by Facebook.
Solution: See here for how to solve this error

About SSHA

The Society of Sexual Health Advisers (SSHA) is a UK national organisation with approximately 300 members out of an estimated 350 sexual health advisers in the country. It provides an opportunity for members to meet and work towards further professional development.

Recent Posts

  • ABC of Sexual Dysfunction September 29, 2019
  • SSHA Branch annual account summary 2017 and 2018 August 8, 2019
  • SSHA Conference 2019 July 21, 2019

Connect with SSHA

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Copyright © 2019 · SSHA - Society of Sexual Health Advisers

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Necessary Always Enabled